IRadimed Valuation
| 46K Stock | 83.50 3.00 3.47% |
At this time, the firm appears to be fairly valued. IRadimed retains a regular Real Value of USD81.71 per share. The prevalent price of the firm is USD83.5. Our model calculates the value of IRadimed from examining the firm fundamentals such as Return On Asset of 0.16, current valuation of 1.03 B, and Return On Equity of 0.25 as well as evaluating its technical indicators and probability of bankruptcy.
Price Book 13.3316 | Enterprise Value 1 B | Enterprise Value Ebitda 46.5353 | Price Sales 12.8424 | Forward PE 47.1698 |
Fairly Valued
Today
Please note that IRadimed's price fluctuation is very steady at this time. Calculation of the real value of IRadimed is based on 3 months time horizon. Increasing IRadimed's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
IRadimed's intrinsic value may or may not be the same as its current market price of 83.50, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 83.5 | Real 81.71 | Hype 84.2 |
The intrinsic value of IRadimed's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence IRadimed's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of IRadimed helps investors to forecast how IRadimed stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of IRadimed more accurately as focusing exclusively on IRadimed's fundamentals will not take into account other important factors: IRadimed Cash |
|
About IRadimed Valuation
The stock valuation mechanism determines IRadimed's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of IRadimed based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of IRadimed. We calculate exposure to IRadimed's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of IRadimed's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 64.8 M | 36.7 M |
IRadimed Quarterly Retained Earnings |
|
Additional Tools for IRadimed Stock Analysis
When running IRadimed's price analysis, check to measure IRadimed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy IRadimed is operating at the current time. Most of IRadimed's value examination focuses on studying past and present price action to predict the probability of IRadimed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move IRadimed's price. Additionally, you may evaluate how the addition of IRadimed to your portfolios can decrease your overall portfolio volatility.